Gloss, Brian

Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In Vivo

Milone, M. C., Fish, J. D., Carpenito, C., Carroll, R. G., Binder, G. K., Teachey, D., Samanta, M., Lakhal, M., Gloss, B., Danet-Desnoyers, G., et al. (2009) · Molecular Therapy

CAR-T cell therapy researchImmunotherapy and Immune Responses

Cited by 1,197

Investigation of product-derived lymphoma following infusion of piggyBac-modified CD19 chimeric antigen receptor T cells

Micklethwaite, K. P., Gowrishankar, K., Gloss, B. S., Li, Z., Street, J. A., Moezzi, L., Mach, M. A., Sutrave, G., Clancy, L. E., Bishop, D. C., et al. (2021) · Blood

CAR-T cell therapy researchVirus-based gene therapy research

Cited by 226

Development of CAR T-cell lymphoma in 2 of 10 patients effectively treated with piggyBac-modified CD19 CAR T cells

Bishop, D. C., Clancy, L. E., Simms, R., Burgess, J., Mathew, G., Moezzi, L., Street, J. A., Sutrave, G., Atkins, E., McGuire, H. M., et al. (2021) · Blood

CAR-T cell therapy researchLymphoma Diagnosis and Treatment

Cited by 177

Targeting inflammation with chimeric antigen receptor macrophages using a signal switch

Cao, Q., Wang, Y., Chen, J., Wang, R., Chen, T., Gloss, B., Read, S. A., Wang, X., Lee, V. W. S., Clancy, L., et al. (2025) · Nature Biomedical Engineering

CAR-T cell therapy researchImmune cells in cancer

Cited by 50